LCTCOTCLaboratory Analytical InstrumentsFiscal year ends December 31
Lifeloc Technologies, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.81−0.19 (-4.63%)
Close on Oct 19, 2026
- Market cap
- $10.50M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
40.3%+6.0 pts over 5 years
Operating margin
-13.6%+4.6 pts over 5 years
Net margin
-27.4%−12.9 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +5.7% | +2.1% | +7.3% | +0.2% | |
| Gross profit | +5.7% | +5.8% | +10.8% | -1.9% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 7.7% | -14.5% | -47.8% | |
| Return on assets | 5.5% | -10.5% | -32.1% | |
| Current ratio | 7.31 | 4.07 | 5.10 | |
| Debt to equity | 0.25 | 0.22 | 0.26 | |
| Net debt to EBITDA | -2.48× | 1.10× | -0.40× | |
| Interest coverage | 9.6× | -20.6× | -10.3× | |
| Inventory turnover | 5.1× | 1.9× | 1.9× | |
| Capex to revenue | 0.5% | 0.4% | 5.1% | |
| Diluted shares | 3M | 2M | 3M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Lifeloc Technologies generated $2.59M from operations and spent $1.49M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$2.59M
Used
$1.49M
Capital expenditure$1.49M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-27.4%
×Asset turnover1.17×
×Equity multiplier1.49×
=Return on equity, FY2025-47.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -27.4% | 1.17× | 1.49× | -47.8% |
| FY2024 | -12.3% | 0.98× | 1.38× | -16.7% |
| FY2023 | 2.2% | 1.08× | 1.38× | 3.3% |
| FY2022 | -5.4% | 0.97× | 1.37× | -7.1% |
| FY2021 | 9.6% | 0.81× | 1.40× | 10.8% |
| FY2020 | -14.5% | 0.72× | 1.38× | -14.5% |
| FY2019 | 7.2% | 1.01× | 1.34× | 9.7% |
| FY2018 | 2.6% | 1.03× | 1.35× | 3.6% |
| FY2017 | 0.2% | 0.99× | 1.37× | 0.2% |
| FY2016 | 5.2% | 1.06× | 1.39× | 7.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$2.47M
- Cash generatingOperating cash flow above zero-$499.32K
- Return on assets improvedROA up on the prior year-12.1% → -28.3%
- Earnings backed by cashOperating cash flow above net income-$499.32K vs -$2.47M
- Less leverageLong-term debt to assets fell12.8% → 15.8%
- Better liquidityCurrent ratio rose6.85 → 5.10
- No dilutionShare count did not rise3M → 3M
- Gross margin improvedGross margin up on the prior year40.36% → 40.35%
- More efficientAsset turnover rose0.98 → 1.03